Minnesota is continuing to experience an unprecedented rise in the use of prescription opioids. The problems associated with the increase of opioid use are statewide and include increased prevalence of addiction, pre-natal exposure to opioids, overdose and death. In order to stem the tide, the Department of Human Services is looking into pursuing three Substance Abuse and Mental Health Services Administration (SAMHSA) grants to address the opiate epidemic. We have provided a brief summary of these grants below and additional information is included in the SAMHSA Opioid Related Grants Document.
If Minnesota were to be selected for all three awards and then subsequently receive ongoing funding for each of the grant periods, the total amount of funding would be $9,708,080 towards addressing the opiate epidemic in Minnesota.
SAMHSA Grants that ADAD is looking into pursuing:
1. Strategic Prevention Framework for Prescription Drugs
The grant is designed to raise awareness about the dangers of sharing medications, work with pharmaceutical and medical communities on the risks of overprescribing to young adults. The grant will be utilized to raise community awareness by bringing prescription drug abuse prevention activities and education to schools, communities, parents, prescribers and their patients.
2. Targeted Capacity Expansion: Medication Assisted Treatment
The grant is designed to expand/enhance access to medication-assisted treatment (MAT) services for persons with opioid use disorder seeking or receiving MAT with an experienced organization, providing these services in the geographical area for a minimum of two years, that can offer an array of services with evidence based treatments integrated with primary care. A diversion mitigation plan is required, as well as a screening requirement for MAT appropriateness. If selected, we would be seeking to implement the Medication Assisted Recovery Model.
SAMHSA’s desired outcomes include:
DHS expected outcomes:
3. Prevent Prescription Drug/Opioid Overdose-Related Deaths
The grant is designed to reduce the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years and older by training first responders and other key community sectors on the prevention of prescription drug/opioid overdose-related deaths and implementing secondary preventions strategies, including the purchase and distribution of naloxone to first responders.